Back
Novartis AG 10K Form
Buy
93
NVSEF
Novartis AG
Last Price:
$152.77
Seasonality Move:
1.38%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NVSEF News And Ratings
See the #1 stock for the next 7 days that we like better than NVSEF
NVSEF Financial Statistics
Sales & Book Value
| Annual Sales: | $54.5B |
|---|---|
| Cash Flow: | $1.1B |
| Price / Cash Flow: | 18.83 |
| Annual Sales: | $24.18 |
| Price / Book: | 6.35 |
Profitability
| EPS (TTM): | 7.15730 |
|---|---|
| Net Income (TTM): | $14B |
| Gross Margin: | $40.8B |
| Return on Equity: | 32.34% |
| Return on Assets: | 13.19% |
Novartis AG Earnings Forecast
Key Novartis AG Financial Ratios
-
The Gross Profit Margin over the past 33 years for NVSEF is 74.88%.
-
The Selling, General & Administrative Expenses for NVSEF have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 19.60% of Revenue.
-
The Interest Expense is 8.19% of Operating Income.
-
The Net Earning history of NVSEF is 25.61% of Total Revenues.
-
Per Share Earnings over the last 33 years have been positive in 22 years.
Novartis AG Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | NVSEF |
| Website: | novartis.com |
Debt
| Debt-to-Equity Ratio: | 0.77 |
|---|---|
| Current Ratio: | 1.12 |
| Quick Ratio: | 0.75 |
Price-to-Earnings
| Trailing P/E Ratio: | 21.36 |
|---|---|
| Forward P/E Ratio: | 0 |
NVSEF Technical Analysis vs Fundamental Analysis
Buy
93
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy or a Sell?
-
Novartis AG stock is rated a BuyThe current Novartis AG [NVSEF] share price is $152.77. The Score for NVSEF is 93, which is 86% above its historic median score of 50, and infers lower risk than normal.